List of Excipients in API upadacitinib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing upadacitinib
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
AbbVie Inc | RINVOQ | upadacitinib | 0074-2306 | CELLULOSE, MICROCRYSTALLINE | 2036-10-17 |
AbbVie Inc | RINVOQ | upadacitinib | 0074-2306 | FERRIC OXIDE RED | 2036-10-17 |
AbbVie Inc | RINVOQ | upadacitinib | 0074-2306 | FERROSOFERRIC OXIDE | 2036-10-17 |
AbbVie Inc | RINVOQ | upadacitinib | 0074-2306 | HYPROMELLOSE | 2036-10-17 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for upadacitinib
Excipient focus: CELLULOSE, MICROCRYSTALLINE
upadacitinib drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
AbbVie Inc | upadacitinib | 0074-2306 |
>Company | >Ingredient | >NDC |
upadacitinib drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
upadacitinib drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
AbbVie Inc | upadacitinib | 0074-2306 |
>Company | >Ingredient | >NDC |
upadacitinib drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
upadacitinib drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
AbbVie Inc | upadacitinib | 0074-2306 |
>Company | >Ingredient | >NDC |
upadacitinib drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
upadacitinib drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
AbbVie Inc | upadacitinib | 0074-2306 |
>Company | >Ingredient | >NDC |
upadacitinib drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
upadacitinib drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
AbbVie Inc | upadacitinib | 0074-2306 |
>Company | >Ingredient | >NDC |
upadacitinib drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
upadacitinib drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
AbbVie Inc | upadacitinib | 0074-2306 |
>Company | >Ingredient | >NDC |
upadacitinib drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
upadacitinib drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
AbbVie Inc | upadacitinib | 0074-2306 |
>Company | >Ingredient | >NDC |
upadacitinib drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
upadacitinib drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
AbbVie Inc | upadacitinib | 0074-2306 |
>Company | >Ingredient | >NDC |
upadacitinib drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
upadacitinib drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
AbbVie Inc | upadacitinib | 0074-2306 |
>Company | >Ingredient | >NDC |
upadacitinib drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
upadacitinib drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
AbbVie Inc | upadacitinib | 0074-2306 |
>Company | >Ingredient | >NDC |
upadacitinib drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TARTARIC ACID
upadacitinib drug variants containing TARTARIC ACID
Company | Ingredient | NDC |
---|---|---|
AbbVie Inc | upadacitinib | 0074-2306 |
>Company | >Ingredient | >NDC |
upadacitinib drug variants not containing TARTARIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
upadacitinib drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
AbbVie Inc | upadacitinib | 0074-2306 |
>Company | >Ingredient | >NDC |
upadacitinib drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.